Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma
Published Online: 2017-11-08
Journal: Investigational New Drugs•Publisher: Springer Science and Business Media LLC
Authors: Ekkhard Schütz•Glen J. Weiss•Howard Urnovitz•Julia Beck•Kirsten Bornemann-Kolatzki•Lisa Blaydorn•Vivek Khemka
